About DongKoo Bio& Pharma
DongKoo Bio& Pharma is a company based in Seoul (South Korea) founded in 1970. DongKoo Bio& Pharma offers products and services including Specialist Medicines, General Medicines, Cosmetics, and Medical Devices. DongKoo Bio& Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Seoul, South Korea
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name (주)동구바이오제약
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DongKoo Bio& Pharma
DongKoo Bio& Pharma offers a comprehensive portfolio of products and services, including Specialist Medicines, General Medicines, Cosmetics, and Medical Devices.
Prescription drugs for skin and general treatments
Over-the-counter drugs for everyday health
Skin care products for personal wellness
Equipment for medical and diagnostic use
Funding Insights of DongKoo Bio& Pharma
Detailed funding history for DongKoo Bio Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DongKoo Bio& Pharma
Investment portfolio details for DongKoo Bio Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DongKoo Bio Pharma
Detailed financials for DongKoo Bio Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dongkoo Bio& Pharma Comparisons
Peer comparison for DongKoo Bio Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DongKoo Bio& Pharma
DongKoo Bio& Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of DongKoo Bio Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dongkoo Bio& Pharma
Complete news archive for DongKoo Bio Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DongKoo Bio& Pharma
DongKoo Bio& Pharma was founded in 1970.
DongKoo Bio& Pharma is headquartered in Seoul, South Korea.
Youngjun Cho is the current CEO of DongKoo Bio& Pharma.
DongKoo Bio Pharma is a diversified company focused on generic medicines, OTC, stem cell extraction kits, medical apparatus, Cosmetics CMO services. The company has a strong pipeline of products in various stages of developments including clinical trials, preclinical, process validation, pilot test formulation. The company is developing medicines for dermatology, urology, circulatory system, respiratory system, neuropsychiatry system, bones, and joints. The company also offers CMO services for tablets, hard capsules, soft gelatin capsules, liquids, powder external use products. It has developed stem cell extraction kits for aesthetic surgery anti-snoring oral devices for sleep apnea. The company has products in the market such as Cenilton for prostate treatment (partnership with Cerbios-pharma), Ventux for active probiotic intestinal treatment, and Dentheth ointment for gum disease treatment. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.
DongKoo Bio& Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
DongKoo Bio& Pharma offers Specialist Medicines, General Medicines, Cosmetics, and Medical Devices.